Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.705 USD | -1.98% | -3.39% | -35.20% |
May. 07 | Transcript : AbCellera Biologics Inc., Q1 2024 Earnings Call, May 07, 2024 | |
May. 07 | AbCellera Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 586
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Antibodies
100.0
%
| 485 | 100.0 % | 38 | 100.0 % | -92.17% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
94.7
%
| 484 | 99.8 % | 36 | 94.7 % | -92.57% |
United States
5.3
%
| 1 | 0.2 % | 2 | 5.3 % | +66.67% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 39 | 12-11-07 | |
Founder | - | 12-11-07 | |
Carl Lars Hansen
CEO | Chief Executive Officer | 49 | 12-11-07 |
Andrew Booth
DFI | Director of Finance/CFO | 51 | 16-05-31 |
Tryn Stimart
CMP | Compliance Officer | 54 | 19-07-31 |
Dylan Neid
CTO | Chief Tech/Sci/R&D Officer | - | - |
Melanie Solomon
IRC | Investor Relations Contact | - | - |
Graham Craig
PRN | Corporate Officer/Principal | - | - |
Neil Aubuchon
PRN | Corporate Officer/Principal | 54 | 21-12-01 |
Dani Sidik
AUD | Comptroller/Controller/Auditor | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Montalbano
BRD | Director/Board Member | 59 | 20-10-31 |
Michael Hayden
BRD | Director/Board Member | 72 | 19-09-30 |
Andrew Lo
BRD | Director/Board Member | 63 | 21-12-06 |
Andrew Booth
DFI | Director of Finance/CFO | 51 | 16-05-31 |
Carl Lars Hansen
CEO | Chief Executive Officer | 49 | 12-11-07 |
Founder | 39 | 12-11-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 294,054,356 | 211,769,370 ( 72.02 %) | 0 | 72.02 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.80% | 1.11B | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+50.30% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- ABCL Stock
- Company AbCellera Biologics Inc.